This Handbook provides an overview of federal patent and trademark law. Information discussed includes types of patents and trademarks, duration of registration, requirements for obtaining, a guide to the application process, protecting your patent or trademark, and much more in 18 pages of materials.
Patent Use Can Foramen Ovale Cause Stroke In California
State:
Multi-State
Control #:
US-003HB
Format:
Word;
PDF;
Rich Text
Instant download
Description
Free preview
Form popularity
FAQ
Recurrent stroke rates after PFO closure was slightly higher in patients aged 18–45 compared to those aged 46–59 (1.5% vs. 1.3%, respectively). Contrary to that, in a meta-analysis by Xu et al. (40) younger patients had fewer outcomes of recurrent neurological episodes after PFO closure.
The absolute risks of ischemic stroke in patients with PFO closure and in the general population, respectively, were 1.4% (95% CI: 0.8%-2.3%) and 0.1% (95% CI: 0.0%-0.1%) at 1 year, 1.4% (95% CI: 0.8%-2.3%) and 0.2% (95% CI: 0.2%-0.4%) at 2 years, 2.2% (95% CI: 1.3%-3.5%) and 0.4% (95% CI: 0.2%-0.5%) at 3 years, and ...
Patent foramen ovale is prevalent in 20–34% of the population1 and are generally benign and asymptomatic. Occasionally, they can give rise to systemic emboli, which can cause both ocular and cerebral ischaemic events, such as cryptogenic strokes.
Patent foramen ovale is prevalent in 20–34% of the population1 and are generally benign and asymptomatic. Occasionally, they can give rise to systemic emboli, which can cause both ocular and cerebral ischaemic events, such as cryptogenic strokes.
A healthcare provider may recommend a PFO closure procedure if: You've had a transient ischemic attack (TIA) more than once. You've had cryptogenic (from an unknown cause) strokes more than once. You have a low level of oxygen in your blood.
PFO closure is used either for primary or secondary prevention of stroke. It has been proposed that PFO closure is an effective treatment to prevent recurrent stroke or TIA in patients with cryptogenic stroke if the shunt grade of the PFO is greater than moderate 10.
A patent foramen ovale (PFO) is a highly prevalent finding in cryptogenic ischaemic stroke, particularly in young adults. A common challenge in clinical practice is to distinguish between incidental and pathogenic PFO.
Evidence suggests PFO has a genetic predisposition. Genetic variants associated with PFO would serve as biomarkers used for screening high risk individuals. Specific genes that contribute to FO closure are largely unknown. This is attributed to our incomplete understanding of the physiological process of FO closure.
Possible Complications Some people may have a condition shortness of breath and low arterial blood oxygen levels when sitting or standing. This is called platypnea-orthodeoxia. This is rare. Rarely, people with PFOs may have a higher rate of a certain type of stroke (called paradoxical thromboembolic stroke).
In conclusion, in patients between 18 and 60 years of age who had had a cryptogenic ischemic stroke, there was no significant benefit of closure of a patent foramen ovale over medical therapy alone in the intention-to-treat analysis.
